Gene Therapy for FTD: What Do I Need to Know?

Research1/18/2024 9:00 PM

Go to Registration Page


In the last several years, new clinical trials have begun for drugs that can potentially slow or stop the progression of FTD caused by specific genes. Gene therapy and gene editing technologies that have been available for other diseases and conditions hold promise for a treatment for FTD, but, as with all new medical interventions, people have many questions. In this webinar, we will explore the types of interventions being developed for genetic FTD and how to make informed decisions about participating in this type of research. Viewers will be able to understand: What “gene therapy” for FTD means. The major types of gene-related interventions being explored for FTD. What to consider when deciding if this type of research is right for you and your family. Where to go for more information on FTD gene therapy. Additional information on the genetics of FTD, genetic counseling, FTD clinical trials can be found on AFTD’s website.


Rate This Webinar

community rating (0 votes): 
Rate or Review This Webinar


The Association for Frontotemporal Degeneration

The Association for Frontotemporal Degeneration

The Association for Frontotemporal Degeneration (AFTD) offers reliable information, resources, and support for families facing Frontotemporal Dementia (FTD). FTD is caused by degeneration of the frontal and/or temporal lobes of the brain and is the most common form of dementia for people under 60. AFTD provides support groups, resources for diagnosis, and assistance for managing FTD. AFTD also facilitates research participation, advocates for FTD awareness, and offers educational webinars and events. Contact AFTD's HelpLine at 1-866-507-7222 or email for more information.